BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis
Seong Il Seo(Samsung Medical Center), Daqing Wu(Metaclipse Therapeutics (United States)), Ruoxiang Wang(Cedars-Sinai Medical Center), Majd Zayzafoon(University of Alabama at Birmingham), Shareen A. Iqbal(Emory University), Nicole Johnson, Shumin Zhang(North Sichuan Medical University), Wei Qian(Georgia Institute of Technology), Lajos Gera(Rutgers, The State University of New Jersey), Haiyen E. Zhau(Cedars-Sinai Medical Center), Leland W.K. Chung(VA Palo Alto Health Care System)
Cited by 22
Related Papers
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
|Journal of the American Chemical Society|2006|5.4k
Prospective Study of Body Mass Index, Weight Change, and Risk of Adult-onset Asthma in Women
|Archives of Internal Medicine|1999|854
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
|PubMed|1994|739
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
|Nature Protocols|2007|520